Calendar year second quarter organic growth continued at a strong pace for major US publicly held instrument and laboratory product companies. However, currency headwinds, as well as weakness in industrial markets and Japan expunged organic growth. Currency reduced gains by about 7%, resulting in roughly flat second quarter average sales growth. Pharmaceutical and biotechnology markets […]
Instrument Design Awards: New Ideas The annual IBO Design Awards recognize advances in the industrial design of lab instruments, lab equipment (page 6) and portable instruments (page 7). To be eligible, products must have begun commercial shipments between August 1, 2014, and July 31. Criteria include innovation, functionality and utility. Gold Award Fluidigm’s Juno SNP […]
Company Announcements In June, China-based Annoroad and Illumina announced an agreement to jointly develop advanced clinical applications for reproductive health based on NGS, including a user friendly, prenatal DNA diagnostic system. A*STAR Genome Institute of Singapore established a strategic joint lab initiative with Pyrobett, a Singapore-based joint venture of BMS and QIAGEN, to develop a […]
With the first half of the year behind us, let us reflect on the state of the analytical and life science instrumentation and lab products market, how it has developed thus far and what is in store for the rest of 2015. The original January forecast (see IBO 1/15/15) was published without the benefit of […]
Wilmington, DE 7/13/15—454 Life Sciences, a Roche business, has filed a patent infringement suit in the US District Court in Delaware against Ion Torrent, a Thermo Fisher Scientific business. The complaint alleges infringement of three patents related to performing emulsion PCR and DNA sequencing of emulsion PCR products: US Patent Nos. 7,323,305 (Methods of Amplifying […]
Since its introduction in 2013, the use of the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) 9 system for genome editing has exploded. Products for CRISPR/Cas9 range from plasmids and oligonucleotides to transgenic animals and screening services. According to Bioinformatics LLC’s report, “The Market for CRISPR/Cas9 Genome Editing Products,” published in May and based […]
Company Announcements PointCross Life Sciences announced in April a strategic partnership with InterpretOmics to integrate their respective RDIS and iOmics platforms across nonclinical, clinical and genomic biomarkers for targeted drug development and patient stratification. In May, Pacific Biosciences and RainDance Technologies partnered to codevelop and comarket novel solutions for de novo whole genome assembly. These […]
Company Announcements In March, QIAGEN signed a commercial agreement with GATC Biotech to provide GATC clients with full access to its Ingenuity Variant Analysis solution. The access includes interpretation services and direct access as a feature of GATC’s services. In April, QIAGEN announced a reseller agreement with BGI to provide its Ingenuity Variant Analysis in […]
IBO has moved up its quarterly financial review of major publicly held instrument and lab product businesses to the mid-month issues in order to provide more time-sensitive reporting. In addition, IBO has reorganized its Sales Indexes to one primary Laboratory Instruments and Products Sale Index, which will be presented in the May 31 issue. These […]
Company Announcements In March, Qlucore partnered with TATAA Biocenter, which will use Qlucore’s Omics Explorer Software for providing NGS data analysis and for training courses. Illumina formed a collaboration with Merck Serono to develop a universal NGS-based oncology diagnostic. The assays will be used to detect and measure multiple variants simultaneously to support clinical trials. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
